BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/11/2026 6:12:01 AM | Browse: 3 | Download: 0
 |
Received |
|
2026-01-16 06:00 |
 |
Peer-Review Started |
|
2026-01-16 06:01 |
 |
First Decision by Editorial Office Director |
|
2026-01-28 09:30 |
 |
Return for Revision |
|
2026-01-28 09:30 |
 |
Revised |
|
2026-02-03 14:15 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2026-03-04 02:39 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-03-04 09:39 |
 |
Articles in Press |
|
2026-03-04 09:39 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2026-07-31 06:46 |
 |
Publish the Manuscript Online |
|
2026-08-11 06:12 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© Author(s) (or their employer(s)) 2026. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Mathematical & Computational Biology |
| Manuscript Type |
Correspondence |
| Article Title |
Letter to the Editor: Integrative mechanistic exploration in gastrointestinal therapeutics: Exemplified by Chaihu-Shugan-San for chronic atrophic gastritis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Yan Pan and Fu-Yong Jiao |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Fu-Yong Jiao, MD, PhD, Shaanxi Kawasaki Disease Diagnosis and Treatment Center, Children’s Hospital, Shaanxi Provincial People’s Hospital, Xi’an Jiaotong University, No. 256 Youyi West Road, Beilin District, Xi’an 710000, Shaanxi Province, China. 3105089948@qq.com |
| Key Words |
Chronic atrophic gastritis; Chaihu-Shugan-San; Network pharmacology; Nuclear factor-kappa B; Gut microbiota; Integrative medicine; Translational research |
| Core Tip |
This paper emphasizes that the research of song et al is an example of the integrated research of gastroenterology. Through the combination of network pharmacology, experimental validation and microbiome analysis, this study clarified how Chaihu-Shugan-San can improve chronic atrophic gastritis by double inhibiting inflammation and apoptosis driven by nuclear factor kappaB, and regulating intestinal flora. This paper critically evaluates this methodology as a blueprint for future research on complex botanical drugs, and emphasizes the need for subsequent clinical trials, standardization of phytochemistry, and the development of integrated biomarker groups, in order to translate these mechanistic insights into personalized clinical practice for precancerous lesions. |
| Publish Date |
2026-08-11 06:12 |
| Citation |
Pan Y, Jiao FY. Letter to the Editor: Integrative mechanistic exploration in gastrointestinal therapeutics: Exemplified by Chaihu-Shugan-San for chronic atrophic gastritis. World J Gastroenterol 2026; 32(33): 118981
|
| URL |
https://www.wjgnet.com/1007-9327/full/v32/i33/118981.htm |
| DOI |
https://doi.org/10.3748/wjg.118981 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.